outcome measures

Some of these challenges include diagnostic issues, patient heterogeneity, placebo response, and our subjective outcome measures.

Secondary outcome measures were end of treatment virological response, biochemical response, histological response, and adverse events.

MAIN OUTCOME MEASURES: Fracture healing, time to full weight bearing, mal union, nonunion, and the presence of any hardware failure.

The results showed that the wavelet had a reasonable and clear process , and its outcome measures were time saving .

Main Outcome Measures Composite of major bleeding, minor bleeding, or major vascular access-site complications up to 48 hours after PCI.

Detailed fracture pattern and treatment-related results in terms of validated outcome measures are still lacking.

Main Outcome Measures Preoperative corneal thickness, visual acuity, changes of corneal topography, diopter, and number of operations.

Main Outcome Measures Intraocular pressure, phacoemulsification complications, re-open rate of anterior chamber angle.

Main Outcome Measures The primary outcome measure was occurrence of at least 1 colorectal adenoma.

MAIN OUTCOME MEASURES: Virological , immunological and clinical evaluations were performed before and during treatment.

Main Outcome Measures. Sexual behaviors and mental perception , satisfaction and expectations concerning sexual life .

MAIN OUTCOME MEASURES: Amount of reduction in exophthalmos after surgery and incidence of induced postoperative diplopia.

The secondary outcome measures are cardiovascular events, quality of life, costs and incremental cost effectiveness ratios.

Main Outcome Measures: Whole-body insulin sensitivity, muscle glucose transport, and muscle insulin signaling were assessed.

Main Outcome Measures : We measured incidence, clinical presentation, and course of postpartum thyroiditis.

Outcome Measures: Mortality was the primary outcome.

Main Outcome Measures: Findings from commonly used hyperactivity ratings, attention tests, and sleepiness tests.

Outcome measures included macular edema incidence, central field retinal thickness as measured by OCT, and best-corrected visual acuity.

Main Outcome Measures The primary end point was a composite of initial fatal or nonfatal coronary event or stroke or revascularization.

MAIN OUTCOME MEASURES: Determination of the choline acetyltransferase activity in the groups.

MAIN OUTCOME MEASURES: Gross morphology of reconstructed three-dimensional model and intact material mandible model.

Main Outcome Measures: Primary safety end points were the rates and severity of solicited and unsolicited adverse events.

MAIN OUTCOME MEASURES: Occurrence of branches of hepatic portal vein; clearness and satiation of the vessel wall.

Main outcome measures Recurrence rate, complication rate, hospital stay, nodal counts, blood loss, operating time.

MAIN OUTCOME MEASURES: Cell growth and osteogenic differentiation were observed by inverted microscopy.

Main outcome measures Rate ratio for stroke in periods of time exposed to antipsychotics compared with unexposed periods.

Main Outcome Measures Hematologic response, relapse, clonal evolution, and survival.

MAIN OUTCOME MEASURES: Cell growth was observed under an inverted microscope. Cell phenotype was detected by flow cytometry.

The population and sample, research design, outcome measures, and data analysis procedures are described in this section.

MAIN OUTCOME MEASURES: Brain tissue pathomorphology was measured by Haematoxylin and Eosin Staining.

For assessing statistical significance of improvement in the outcome measures within each treatment group, a paired t test was used.

MAIN OUTCOME MEASURES: The growth condition of chondrocytes was observed by scanning electron microscope.

MAIN OUTCOME MEASURES: The lesion volume and the change of temperature with time around single radiofrequency electrodes in bone tissue.

Main Outcome Measures: A detailed characterization of androgen metabolism was performed.

Main Outcome Measures Rates of the 3 types of surgery, major complications, postoperative mortality, and resource use.

Outcome measures were compared in a univariate, per-protocol analysis.

Main Outcome Measures: Torsion, bending, and axial stiffness and axial failure force after cyclic loading.

MAIN OUTCOME MEASURES: Cell morphous was observed with an inverted microscope to draw growth curve.

MAIN OUTCOME MEASURES: The stress and stress changes of mandible when impacted from different angles.

Outcome measures included the duration of hospice care received and various measures of quality of death.

MAIN OUTCOME MEASURES: Effects and complications after injection.

MAIN OUTCOME MEASURES: The maximum load, maximum stress, maximum strain and stress-strain curve.

Main outcome measures Women had three cognitive assessments at two year intervals by telephone.

Main Outcome Measures Invasive breast cancer event (recurrence or new primary) or death from any cause.

MAIN OUTCOME MEASURES: Incident dementia and AD determined by expert panel consensus.

Main Outcome Measures The eye refraction of guinea pigs included the scope, cylinder and the equivalent power.

MAI OUTCOME MEASURES: Operation time, bleeding volume and hip dislocation after THA.

MAIN OUTCOME MEASURES: The accuracy and efficacy of virtual anatomical models.

MAIN OUTCOME MEASURES: Bending ability and distorting ability.

MAIN OUTCOME MEASURES: Pullout strength and injuries to pedicle and vertebra.

MAIN OUTCOME MEASURES: Typing of structural abnormity of vertebrobasilar artery system.

MAIN OUTCOME MEASURES: Strain changes on the medial wall and dome region of acetabulum.

It introduced the aim of electrocardiogram, main outcome measures, notes, and the method of record.

MAIN OUTCOME MEASURES: The ratio of absorbance value between ALP and total protein.

MAIN OUTCOME MEASURES: The proliferation rate and the ALP activity of osteoblasts.

Main Outcome Measures Incident cancer and cancer mortality over a follow-up period of 10 years (1995-2005 with a follow-up rate of 100%).

The primary outcome measures will be cardiovascular risk factors.

Main Outcome Measures Glare in anterior chamber, membranes on surface of intraocular lens.

TABLE 2 lists the clinical outcome measures in the pioglitazone and control groups of the 19 individual trials.

MAIN OUTCOME MEASURES: The primary efficacy end points were nasal symptoms resolution during acute illness (visits 1 and 2).

Individualized outcome measures in community health service

development of causation statements , actions and recommendations and key outcome measures - see

Compare process measures with outcome measures of sanitarian quality

adequate processes of care and ways to improve the reliability of clinical outcome measures;

Primary outcome measures were the rates of nonunion and symptomatic malunion;

The types of outcome measures